Related Experiment Video
Updated: Oct 17, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Cystic fibrosis and the pseudomonads
1Microbiology Department, Huddersfield Royal Infirmary, Lindley, England, UK.
Abstract:
The microbiology of pulmonary disease in cystic fibrosis has altered over the past 10 years. The major pathogens in this disease are now Pseudomonas aeruginosa and, increasingly, Pseudomonas cepacia. P. aeruginosa respiratory infection in these patients is rarely eradicated and this is often the only pathogen found at post-mortem. The most important points in the pathogenesis of this infection are probably the protective role of the bacterial mucoid exopolysaccharide and the interaction of various other bacterial factors with the immune system of the body. P. cepacia has recently emerged as the common isolate from the lungs of cystic fibrosis patients. The actual role of this organism in the progression of lung disease is poorly understood. There has been some speculation about the role of cross-infection in the acquisition of both of these organisms. The treatment of these infections is problematical because of the altered antimicrobial pharmaco-kinetics within the cystic fibrotic lung and the resistant properties of the organisms involved. Approaches which have been suggested recently include immunological interventions and genetic therapy.
Insights
The microbiology of cystic fibrosis lung disease has shifted, with Pseudomonas aeruginosa and Pseudomonas cepacia becoming dominant pathogens. Understanding their pathogenesis and developing new treatments are crucial for managing this progressive pulmonary condition.
Area of Science:
- Medical Microbiology
- Pulmonary Medicine
- Infectious Diseases
Background:
- Cystic fibrosis (CF) lung infections have evolved, with Pseudomonas aeruginosa and Pseudomonas cepacia now being the primary bacterial pathogens.
- Pseudomonas aeruginosa infections in CF patients are persistent, often remaining the sole pathogen identified post-mortem.
- The pathogenesis involves bacterial factors like mucoid exopolysaccharides and interactions with the host immune system.
Purpose of the Study:
- To review the changing landscape of CF lung microbiology.
- To discuss the pathogenesis of key CF pathogens.
- To explore challenges and potential future therapeutic strategies for CF-related lung infections.
Main Methods:
- Literature review of recent studies on CF pulmonary microbiology.
- Analysis of pathogen prevalence and clinical significance.
- Discussion of treatment challenges and emerging therapeutic approaches.
Main Results:
- Pseudomonas aeruginosa and Pseudomonas cepacia are the leading causes of CF lung disease.
- The mucoid exopolysaccharide of P. aeruginosa plays a significant role in infection persistence.
- P. cepacia's role in CF lung disease progression is still under investigation.
- Cross-infection is a potential factor in acquiring these pathogens.
- Treatment is complicated by altered pharmacokinetics and antimicrobial resistance.
Conclusions:
- The microbiology of cystic fibrosis lung disease has significantly changed, necessitating updated management strategies.
- Further research into the pathogenesis of P. cepacia and novel treatment modalities, including immunotherapy and gene therapy, is warranted.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Phylum Actinobacteria
Diversity of Protists II
Atypical Pneumonia

